Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 76 - 100 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species ▲ Gene ID Gene Symbol FlyGlycoDB Evidence References
DOID:9351 diabetes mellitus WB:WBGene00002048 Caenorhabditis elegans 175807 ida-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25469508
DOID:10652 Alzheimer's disease WB:WBGene00003001 Caenorhabditis elegans 176282 lin-12 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:7566091
DOID:0050742 nicotine dependence WB:WBGene00000054 Caenorhabditis elegans 191602 acr-15 mutant phenotype evidence used in manual assertion
  • PMID:17081982
DOID:1289 neurodegenerative disease WB:WBGene00003168 Caenorhabditis elegans 181728 mec-4 mutant phenotype evidence used in manual assertion
  • PMID:8107806
DOID:13359 Ehlers-Danlos syndrome WB:WBGene00005021 Caenorhabditis elegans 176382 sqv-3 mutant phenotype evidence used in manual assertion
  • PMID:12417421
DOID:9970 obesity WB:WBGene00001234 Caenorhabditis elegans 173169 eif-6 mutant phenotype evidence used in manual assertion
  • PMID:34492009
DOID:0050833 orotic aciduria WB:WBGene00011559 Caenorhabditis elegans 176453 umps-1 mutant phenotype evidence used in manual assertion
  • PMID:20148972
  • PMID:24262006
DOID:9351 diabetes mellitus WB:WBGene00003858 Caenorhabditis elegans 176000 ogt-1 mutant phenotype evidence used in manual assertion
  • PMID:31576392
DOID:1826 epilepsy WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 mutant phenotype evidence used in manual assertion
  • PMID:19797046
DOID:14452 hypokalemic periodic paralysis WB:WBGene00000950 Caenorhabditis elegans 181035 deg-1 mutant phenotype evidence used in manual assertion
  • PMID:8994058
DOID:65 connective tissue disease WB:WBGene00022816 Caenorhabditis elegans 176076 fbn-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25798732
DOID:0050742 nicotine dependence WB:WBGene00000054 Caenorhabditis elegans 191602 acr-15 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:17081982
DOID:0050742 nicotine dependence WB:WBGene00000055 Caenorhabditis elegans 179235 acr-16 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:17081982
DOID:14250 Down syndrome WB:WBGene00010757 Caenorhabditis elegans 259529 pad-2 mutant phenotype evidence used in manual assertion
  • PMID:15233996
DOID:1574 alcohol use disorder WB:WBGene00006797 Caenorhabditis elegans 172150 unc-63 mutant phenotype evidence used in manual assertion
  • PMID:25342716
DOID:1826 epilepsy WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:19797046
DOID:670 amphetamine abuse WB:WBGene00000295 Caenorhabditis elegans 180837 cat-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:22642886
DOID:14452 hypokalemic periodic paralysis WB:WBGene00000950 Caenorhabditis elegans 181035 deg-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:8994058
DOID:557 kidney disease WB:WBGene00016848 Caenorhabditis elegans 177557 klo-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:21177529
DOID:670 amphetamine abuse WB:WBGene00000295 Caenorhabditis elegans 180837 cat-1 mutant phenotype evidence used in manual assertion
  • PMID:22642886
DOID:12798 mucopolysaccharidosis WB:WBGene00010722 Caenorhabditis elegans 175063 K09E4.4 sequence orthology evidence used in manual assertion
  • WB:WBPaper00035542
DOID:1289 neurodegenerative disease WB:WBGene00001612 Caenorhabditis elegans 176204 glr-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:31306683
DOID:809 cocaine abuse WB:WBGene00000295 Caenorhabditis elegans 180837 cat-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:22642886
DOID:1289 neurodegenerative disease WB:WBGene00010775 Caenorhabditis elegans 187297 poml-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:26941331
DOID:1574 alcohol use disorder WB:WBGene00006783 Caenorhabditis elegans 176431 unc-47 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25342716

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025